Centaurus Financial Inc. Purchases New Shares in Hercules Capital, Inc. $HTGC

Centaurus Financial Inc. acquired a new stake in Hercules Capital, Inc. (NYSE:HTGC) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 107,436 shares of the financial services provider’s stock, valued at approximately $1,694,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Melia Wealth LLC acquired a new stake in shares of Hercules Capital in the second quarter valued at $8,735,000. Capstone Investment Advisors LLC bought a new position in shares of Hercules Capital in the second quarter valued at about $779,000. Corient Private Wealth LP acquired a new position in Hercules Capital during the 2nd quarter worth about $377,000. Palogic Value Management L.P. acquired a new position in Hercules Capital during the 2nd quarter worth about $679,000. Finally, Bank of America Corp DE bought a new stake in Hercules Capital during the 2nd quarter worth about $4,095,000. Institutional investors and hedge funds own 19.69% of the company’s stock.

Hercules Capital Stock Performance

Shares of NYSE:HTGC opened at $17.55 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.03. Hercules Capital, Inc. has a 1-year low of $13.70 and a 1-year high of $19.62. The stock has a market capitalization of $3.29 billion, a P/E ratio of 8.73 and a beta of 0.79. The business has a 50-day moving average price of $16.30 and a two-hundred day moving average price of $15.65.

Hercules Capital (NYSE:HTGC) last issued its earnings results on Thursday, July 30th. The financial services provider reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. Hercules Capital had a net margin of 67.68% and a return on equity of 16.01%. The company had revenue of $134.41 million for the quarter, compared to analyst estimates of $146.71 million. During the same quarter last year, the firm earned $0.50 EPS. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. Equities analysts predict that Hercules Capital, Inc. will post 1.95 earnings per share for the current year.

Hercules Capital Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 18th. Shareholders of record on Tuesday, August 11th were paid a $0.40 dividend. The ex-dividend date of this dividend was Tuesday, August 11th. This is a boost from Hercules Capital’s previous quarterly dividend of $0.07. This represents a $1.60 dividend on an annualized basis and a yield of 9.1%. Hercules Capital’s payout ratio is 79.60%.

Analysts Set New Price Targets

HTGC has been the subject of several research reports. UBS Group raised their price objective on shares of Hercules Capital from $15.00 to $15.50 and gave the company a “neutral” rating in a research report on Monday, May 18th. Piper Sandler increased their price target on shares of Hercules Capital from $16.50 to $17.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. LADENBURG THALM/SH SH dropped their price objective on shares of Hercules Capital from $21.00 to $20.00 and set a “buy” rating for the company in a research report on Friday, July 31st. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Hercules Capital in a report on Wednesday, June 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $18.46.

Hercules Capital Company Profile

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high?growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.